Camelot Portfolios’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-600
Closed -$82.7K 429
2025
Q4
$82.7K Buy
+600
New +$78.6K 0.05% 260
2024
Q3
Sell
-600
Closed -$63.9K 419
2024
Q2
$63.9K Buy
+600
New +$60.2K 0.04% 282
2019
Q1
Sell
-11,230
Closed -$863K 253
2018
Q4
$863K Buy
11,230
+137
+1% +$10.7K 0.4% 75
2018
Q3
$856K Sell
11,093
-121
-1% -$8.95K 0.39% 70
2018
Q2
$759K Sell
11,214
-941
-8% -$64.9K 0.32% 85
2018
Q1
$881K Sell
12,155
-284
-2% -$21.6K 0.41% 71
2017
Q4
$936K Buy
12,439
+17
+0.1% +$1.28K 0.44% 66
2017
Q3
$956K Buy
12,422
+303
+3% +$22.9K 0.46% 63
2017
Q2
$906K Sell
12,119
-630
-5% -$44.7K 0.45% 58
2017
Q1
$848K Buy
+12,749
New +$850K 0.41% 67
2015
Q1
Sell
-6,917
Closed -$574K 178
2014
Q4
$574K Buy
6,917
+65
+0.9% +$5.39K 0.33% 88
2014
Q3
$578K Buy
6,852
+341
+5% +$27.6K 0.34% 87
2014
Q2
$528K Sell
6,511
-3,120
-32% -$245K 0.34% 86
2014
Q1
$734K Sell
9,631
-12,587
-57% -$917K 0.5% 60
2013
Q4
$1.6M Buy
22,218
+1,403
+7% +$97.5K 1.03% 22
2013
Q3
$1.43M Buy
20,815
+729
+4% +$48.2K 1.05% 22
2013
Q2
$1.27M Buy
+20,086
New +$1.31M 0.97% 24

Other funds holding NVS